215 related articles for article (PubMed ID: 20975707)
1. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes.
Chiefari E; Iiritano S; Paonessa F; Le Pera I; Arcidiacono B; Filocamo M; Foti D; Liebhaber SA; Brunetti A
Nat Commun; 2010 Jul; 1():40. PubMed ID: 20975707
[TBL] [Abstract][Full Text] [Related]
2. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice.
Foti D; Chiefari E; Fedele M; Iuliano R; Brunetti L; Paonessa F; Manfioletti G; Barbetti F; Brunetti A; Croce CM; Fusco A; Brunetti A
Nat Med; 2005 Jul; 11(7):765-73. PubMed ID: 15924147
[TBL] [Abstract][Full Text] [Related]
3. Functional variants of the HMGA1 gene and type 2 diabetes mellitus.
Chiefari E; Tanyolaç S; Paonessa F; Pullinger CR; Capula C; Iiritano S; Mazza T; Forlin M; Fusco A; Durlach V; Durlach A; Malloy MJ; Kane JP; Heiner SW; Filocamo M; Foti DP; Goldfine ID; Brunetti A
JAMA; 2011 Mar; 305(9):903-12. PubMed ID: 21364139
[TBL] [Abstract][Full Text] [Related]
4. Methods to Study Protein-Binding to Pseudogene Transcripts.
Chiefari E; Arcidiacono B; Mirabelli M; Brunetti FS; Greco E; Foti DP; Brunetti A
Methods Mol Biol; 2021; 2324():187-202. PubMed ID: 34165716
[TBL] [Abstract][Full Text] [Related]
5. HMGA1-pseudogene expression is induced in human pituitary tumors.
Esposito F; De Martino M; D'Angelo D; Mussnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Trouillas J; Fusco A
Cell Cycle; 2015; 14(9):1471-5. PubMed ID: 25894544
[TBL] [Abstract][Full Text] [Related]
6. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
[TBL] [Abstract][Full Text] [Related]
7. Regulatory Axis of miR-195/497 and HMGA1-Id3 Governs Muscle Cell Proliferation and Differentiation.
Qiu H; Zhong J; Luo L; Tang Z; Liu N; Kang K; Li L; Gou D
Int J Biol Sci; 2017; 13(2):157-166. PubMed ID: 28255268
[TBL] [Abstract][Full Text] [Related]
8. The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake.
Iiritano S; Chiefari E; Ventura V; Arcidiacono B; Possidente K; Nocera A; Nevolo MT; Fedele M; Greco A; Greco M; Brunetti G; Fusco A; Foti D; Brunetti A
Mol Endocrinol; 2012 Sep; 26(9):1578-89. PubMed ID: 22745191
[TBL] [Abstract][Full Text] [Related]
9. Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells.
Cao YD; Huang PL; Sun XC; Ma J; Jin ZL; Cheng HY; Xu RZ; Li F; Qin SK; Deng YX; Ge XL
Chin Med J (Engl); 2011 Apr; 124(7):1061-8. PubMed ID: 21542969
[TBL] [Abstract][Full Text] [Related]
10. From bending DNA to diabetes: the curious case of HMGA1.
Semple RK
J Biol; 2009; 8(7):64. PubMed ID: 19664187
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
12. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
Liu YL; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
[TBL] [Abstract][Full Text] [Related]
13. [The expression of pseudogene HMGA1L2 in thyroid lesions].
Wang GL; Zhang GC; Li F; Zhao J; Hu WH; Zhang JF; Yin XL; Guo CJ; Jiang JF; Liang WH
Yi Chuan; 2006 Nov; 28(11):1365-70. PubMed ID: 17098703
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling.
Chiefari E; Arcidiacono B; Palmieri C; Corigliano DM; Morittu VM; Britti D; Armoni M; Foti DP; Brunetti A
Sci Rep; 2018 Jun; 8(1):8540. PubMed ID: 29867121
[TBL] [Abstract][Full Text] [Related]
15. Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation.
Martinez Hoyos J; Fedele M; Battista S; Pentimalli F; Kruhoffer M; Arra C; Orntoft TF; Croce CM; Fusco A
Cancer Res; 2004 Aug; 64(16):5728-35. PubMed ID: 15313913
[TBL] [Abstract][Full Text] [Related]
16. HMGA1-pseudogene overexpression contributes to cancer progression.
Esposito F; De Martino M; Forzati F; Fusco A
Cell Cycle; 2014; 13(23):3636-9. PubMed ID: 25483074
[TBL] [Abstract][Full Text] [Related]
17. RNA-Mediated Regulation of HMGA1 Function.
Benecke AG; Eilebrecht S
Biomolecules; 2015; 5(2):943-57. PubMed ID: 26117853
[TBL] [Abstract][Full Text] [Related]
18. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs.
D'Angelo D; Mussnich P; Rosa R; Bianco R; Tortora G; Fusco A
BMC Cancer; 2014 Nov; 14():851. PubMed ID: 25409711
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance.
Arce-Cerezo A; García M; Rodríguez-Nuevo A; Crosa-Bonell M; Enguix N; Peró A; Muñoz S; Roca C; Ramos D; Franckhauser S; Elias I; Ferre T; Pujol A; Ruberte J; Villena JA; Bosch F; Riu E
Sci Rep; 2015 Sep; 5():14487. PubMed ID: 26411793
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin.
Arnoldo L; Sgarra R; Chiefari E; Iiritano S; Arcidiacono B; Pegoraro S; Pellarin I; Brunetti A; Manfioletti G
Sci Rep; 2015 Feb; 5():8552. PubMed ID: 25711412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]